Five years ago this month, Michigan voters opened the door for a full range of stem cell research in the state. Today, that effort is well under way at the University of Michigan, and yielding results that are expanding knowledge of a wide range of diseases.
Recent Posts
- Infant becomes world’s first patient to undergo personalized gene-editing treatment
- Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
- Embryonic macrophages found to control blood stem cell numbers in bone marrow
- Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
- The stem cell race for Parkinson’s disease: Recent studies show significant promise
- New Cell Therapy For Resistant Hodgkins Patients